Phase III Clinical Trial – Novartis
A randomized, double-blind, multicenter study assessing short (16 weeks) and long-term efficacy (up to 1 year), safety, and tolerability of 2 subcutaneous secukinumab dose regimens in adult patients with moderate to severe hidradenitis suppurativa
To participate in your local study, please contact (949) 707-5734 or fill out the form below.
CAIN457M2302
Share this post
Subscribe To Our Newsletter
Get updates and learn from the best
More To Explore
Call us, write us, or knock on our door.
Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.
- 27020 Alicia Parkway , Suite G Laguna Niguel, CA 92677
- Monday - Friday: 8AM - 5PM
- Saturday and Sunday: Closed
- (949) 707-5734
- info@avancetrials.com